Acyclic phosph(on)ate inhibitors of Plasmodium falciparum hypoxanthine-guanine-xanthine phosphoribosyltransferase

Add time:07/22/2019    Source:sciencedirect.com

The pathogenic protozoa responsible for malaria lack enzymes for the de novo synthesis of purines and rely on purine salvage from the host. In Plasmodium falciparum (Pf), hypoxanthine-guanine-xanthine phosphoribosyltransferase (HGXPRT) converts hypoxanthine to inosine monophosphate and is essential for purine salvage making the enzyme an anti-malarial drug target. We have synthesized a number of simple acyclic aza-C-nucleosides and shown that some are potent inhibitors of Pf HGXPRT while showing excellent selectivity for the Pf versus the human enzyme.

We also recommend Trading Suppliers and Manufacturers of 9-(4-hydroxy-2-(hydroxymethyl)butyl)guanine (cas 105868-85-7). Pls Click Website Link as below: cas 105868-85-7 suppliers

Prev:Synthesis, antiviral activity and enzymatic phosphorylation of 9-phosphonopentenyl derivatives of guanine
Next:Inhibition of the RTEM-1 β-lactamase by boronic acids)